Synergistic effects of relaxation and susceptibility in differentiation between compartmentalized and noncompartmentalized tissues

Investigative Radiology

Volumn 33, Issue 5, 1998, Pages 268-272

  Dupas, Benoît ^a,d   Bach Gansmo, Tore ^b   Meflah, Kahled ^a   Muller, Robert N ^c  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF MONS   (Belgium)

^d HÔTEL DIEU   (France)

Author keywords

Contrast media; Double contrast; Kidney; Magnetic resonance imaging

Indexed keywords

DYSPROSIUM; GADOLINIUM;

ANIMAL TISSUE; ARTICLE; CELL COMPARTMENTALIZATION; CONTRAST ENHANCEMENT; DRUG EFFECT; DRUG POTENTIATION; KIDNEY FUNCTION; KIDNEY PARENCHYMA; KIDNEY TUBULE NECROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SIGNAL DETECTION; TISSUE DIFFERENTIATION;

EID: 0031948135     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199805000-00003     Document Type: Article

References (13)

1. Kennan RP, Zhong J, Gore JC. Intra vascular susceptibility contrast mechanisms in tissues. Magn Reson Med 1994;31:9-21.
2. Brasch R. New directions in the development of MR imaging contrast agents. Radiology 1992;183:1-11.
3. Villringer A, Rosen BR, Belliveau JW, et al. Dynamic imaging with lanthanide chelates in the normal brain: Contrast due to magnetic susceptibility effects. Magn Reson Med 1988;6:164174.
4. 2* contrast-enhanced imaging. In: Brasch R, ed. Workshop on contrast-enhanced magnetic resonance. Napa, California: Society for Magnetic Resonance in Medicine, 1991.
5. Ericsson A, Bach-Gansmo T, Niklasson F, Hemmingsson A. Combination of gadolinium and dysprosium chelates as a cellular integrity marker in MR imaging. Acta Radiol 1995;36:41-46.
6. Saeed M, Wendland MF, Masui T, Higgins CB. Reperfused myocardial infarction on T1- and susceptibility-enhanced MRI: Evidence for loss of compartmentalization of contrast media. Magn Res Med 1994;31:31-39.
7. Wickstrom̈ M, Martinussen HJ, Ericsson A, Wickström G, Waldenström A, Hemmingsson A. Double contrast enhanced MR imaging of experimental myocardial infarction in the pig. Acta Radiol 1993;34:64-71.
8. Geschwind J-FH, Wendland MF, Saeed M, Lauerma S, Derugin N, Higgins CB. Identification of myocardial cell death in reperfused myocardial injury using dual mechanisms of contrast-enhancing magnetic resonance imaging. Acad Radiol 1994;1:319-325.
9. Nilsson S, Wickström G, Ericsson A, et al. Double-contrast MR imaging of reperfused porcine myocardial infarction. Acta Radiol 1996;37:27-35.
10. Rocklage SM, Watson A. Chelates of gadolinium and dysprosium as contrast agents for MR imaging. J Magn Reson Imaging 1993;3:167-178.
11. Wang C, Sundin A, Ericsson A, Bach-Gansmo T, Hemmingsson A, Ahlstöm H. Dysprosium enhanced MRI for tumour tissue characterization: An experimental study in a human xenograft model. Acta Radiol 1997;37:2:281-286.
12. Dupas B, Bach-Gansmo T, Nomballais MF, Meflah K. Delineation of liver necrosis using double-contrast enhancement. J Magn Reson Imaging 1997;7:472-477.
13. Fossheim S, Johansson C, Fahlvik A-K, Grace D, Klaveness J. Lanthanide-based susceptibility contrast agents: Assessment of the magnetic properties. Magn Reson Med 1996;35:201-206.